Calsyntenin 3 (CLSTN3) (N-Term) Peptide
-
- Target See all Calsyntenin 3 (CLSTN3) products
- Calsyntenin 3 (CLSTN3)
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- QICYYEILTP NTPFLIDNDG NIENTEKLQY SGERLYKFTV TAYDCGKKRA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-CLSTN3 Antibody(ARP47060_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Calsyntenin 3 (CLSTN3)
- Synonyms
- cstn3 Peptide, cdhr14 Peptide, alcbeta Peptide, MGC84020 Peptide, CDHR14 Peptide, CSTN3 Peptide, Cs3 Peptide, Cst-3 Peptide, mKIAA0726 Peptide, Cstn3 Peptide, calsyntenin 3 Peptide, calsyntenin 3 S homeolog Peptide, CLSTN3 Peptide, clstn3.S Peptide, Clstn3 Peptide
- Background
-
CLSTN3 may modulate calcium-mediated postsynaptic signals. Complex formation with APBA2 and APP,CLSTN3 stabilizes APP metabolism and enhances APBA2-mediated suppression of beta-APP40 secretion, due to the retardation of intracellular APP maturation.
Alias Symbols: CSTN3, KIAA0726, MGC131797, MGC138488, alcbeta, CDHR14
Protein Interaction Partner: APBA2
Protein Size: 956 - Molecular Weight
- 106 kDa
- Gene ID
- 9746
- NCBI Accession
- NM_014718, NP_055533
- UniProt
- Q9BQT9
-